Eculizumab: A Review in Generalized Myasthenia Gravis

Eculizumab: a treatment option for myasthenia gravis?

(2017) Nils Erik Gilhus   LANCET NEUROLOGY

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

(2017) James F Howard et al.   LANCET NEUROLOGY

Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway

(2016) Janus Asbjørn Schatz-Jakobsen et al.   JOURNAL OF IMMUNOLOGY

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

(2016) Nico Melzer et al.   JOURNAL OF NEUROLOGY

International consensus guidance for management of myasthenia gravis

(2016) Donald B. Sanders et al.   NEUROLOGY

An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts

(2015) M. I. Boldingh et al.   Health and Quality of Life Outcomes

Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis

(2015) Jeffrey T. Guptill et al.   Neurotherapeutics

Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms

(2014) Sonia Berrih-Aknin et al.   JOURNAL OF AUTOIMMUNITY

Targeting complement system to treat myasthenia gravis

(2014) Ruksana Huda et al.   REVIEWS IN THE NEUROSCIENCES

Myasthenia gravis: an update for the clinician

(2013) J. P. Sieb   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome

(2013) Gillian M. Keating   DRUGS

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

(2013) James F. Howard et al.   MUSCLE & NERVE

Minimal clinically important difference in myasthenia gravis: Outcomes from a randomized trial

(2013) Hans D. Katzberg et al.   MUSCLE & NERVE

The Myasthenia Gravis-Specific Activities of Daily Living Profile

(2012) Srikanth Muppidi   Annals of the New York Academy of Sciences

The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice

(2012) Ted M. Burns   Annals of the New York Academy of Sciences

Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

(2012) Matthew N Meriggioli et al.   Expert Review of Clinical Immunology

Eculizumab

(2011) Kate McKeage   DRUGS

Complement and cytokine based therapeutic strategies in myasthenia gravis

(2011) Erdem Tüzün et al.   JOURNAL OF AUTOIMMUNITY

A systematic review of population based epidemiological studies in Myasthenia Gravis

(2010) Aisling S Carr et al.   BMC Neurology